🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Treatment Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Followers are urged to message these accounts directly for source information, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and assertions of next-day UK delivery. Vendors market the drug there before directing buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could result in users injecting substances of uncertain source.

Some professionals said the demand for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, advertising, and customer regulations, risking fines, prosecution or imprisonment.

Platform Reaction and Content Elimination

According to the social media company, the service has removed violative material and prohibited associated hashtags and query recommendations. The company said it was dedicated to maintaining the service secure and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Investigations also discovered groups with up to 9,000 participants selling the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of members, filled with images of weight loss, glowing testimonials and detailed instructions for mixing or administering at residence.

Within moments of joining one community, a seller shared contact information, where the majority of transactions occur. The seller sent an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Details and Costs

Inside these groups, messages show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with sterile water, or ready-to-use pens typically sold at £160 for 20mg. When asked how long a injector should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram said it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting materials they cannot confirm. Although the research behind this drug is valid, these digital products may not include what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has previously seen individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet authorized … may expose patients to possibly significant health risks”.